Entry - #122880 - CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS - OMIM
# 122880

CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
2q36.1 Craniofacial-deafness-hand syndrome 122880 AD 3 PAX3 606597
Clinical Synopsis
 

Facies
- Flat facial profile
- Hypertelorism
Nose
- Hypoplastic nose
- Slitlike nares
Ears
- Sensorineural hearing loss
Limbs
- Ulnar deviation of hands
Radiology
- Small maxilla
- Absent or small nasal bones
Inheritance
- Autosomal dominant

TEXT

A number sign (#) is used with this entry because of evidence that craniofacial-deafness-hand syndrome (CDHS) is caused by heterozygous mutation in the PAX3 gene (606597) on chromosome 2q36.


Description

Craniofacial-deafness-hand syndrome (CDHS) is an autosomal dominant disorder characterized by dysmorphic facial features, hand abnormalities, absent or hypoplastic nasal and wrist bones, and severe sensorineural hearing impairment (summary by Gad et al., 2008).


Clinical Features

Sommer et al. (1983) reported a syndrome in mother and infant daughter with features of flat facial profile, hypertelorism, hypoplastic nose with slitlike nares, and a sensorineural hearing loss. Common radiologic findings included small maxilla, absent or small nasal bones, and ulnar deviation of the hands.

Sommer and Bartholomew (2003) provided a follow-up of the family reported by Sommer et al. (1983). A boy born 2 years after the birth of the index patient had precisely the same manifestations as his mother and sister. The mother and daughter were found to have congenital absence of nasolacrimal ducts. The sister and brother grew and developed normally, were very good students, and were active in sports. They were attending college and had goals to be a veterinary technician and a computer technologist, respectively.

Gad et al. (2008) described a 37-year-old woman, born to healthy nonconsanguineous parents, with some, but not all, of the characteristics of CDHS. She had bilateral sensorineural hearing loss, flat facial profile, ptosis, downslanting palpebral fissures, short broad nose, depressed nasal bridge, micrognathia, hypertelorism, telecanthus, high arched palate, limited movement of the wrist with ulnar deviation of the hands, mild flexion contractures of digits 2-5, and clinodactyly of the 5th digits. In addition, CT scan of the face showed underdevelopment of the sinuses ranging from mild to complete aplasia, which had not previously been described in patients with CDHS.


Inheritance

The transmission pattern of CDHS in the family reported by Asher et al. (1996) was consistent with autosomal dominant inheritance.


Molecular Genetics

Because dystopia canthorum, a midfacial alteration, is the most reliable indicator of a PAX3 mutation among Waardenburg syndrome type I families (193500), according to Farrer et al. (1994), and because during murine development the Pax3 gene was expressed in the nasal process (Goulding et al., 1991), Asher et al. (1996) explored the possibility that a mutant allele of PAX3 might be responsible for CDHS. In the mother and child reported by Sommer et al. (1983), Asher et al. (1996) found heterozygosity for a missense mutation (N47K; 606597.0010) in the paired domain of PAX3 by SSCP analysis followed by sequencing. A previously described missense mutation in the same codon (N47H; 606597.0011) was reported by Hoth et al. (1993) in association with Waardenburg syndrome type III (148820). A substitution of a basic amino acid for asparagine at residue 47, conserved in all known murine Pax and human PAX genes, appears to have a more drastic effect on the phenotype than missense, frameshift, and deletion mutations of PAX3 that cause Waardenburg syndrome type I. Among 24 unrelated individuals with WS1 mutations, no 2 had been found to have the same point mutation in the protein-coding region of PAX3, nor did they have a change in the same codon (Farrer et al., 1994). The finding in CDHS provided the first opportunity to compare molecular pathology and clinical heterogeneity between 2 different mutations in the same codon for PAX3.

In a patient with possible CDHS, Gad et al. (2008) performed sequencing of all 9 exons and 20 bp of the flanking introns of the PAX3 gene and did not identify any mutations. The presence of heterozygosity for a PAX3 polymorphism ruled out a full gene deletion, but a partial deletion remained a possible disease mechanism in this patient.


REFERENCES

  1. Asher, J. H., Jr., Sommer, A., Morrell, R., Friedman, T. B. Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome. Hum. Mutat. 7: 30-35, 1996. [PubMed: 8664898, related citations] [Full Text]

  2. Farrer, L. A., Arnos, K. S., Asher, J. H., Jr., Baldwin, C. T., Diehl, S. R., Friedman, T. B., Greenberg, J., Grundfast, K. M., Hoth, C., Lalwani, A. K., Landa, B., Leverton, K., Milunsky, A., Morell, R., Nance, W. E., Newton, V., Ramesar, R., Rao, V. S., Reynolds, J. E., San Agustin, T. B., Wilcox, E. R., Winship, I., Read, A. P. Locus heterogeneity for Waardenburg syndrome is predictive of clinical subtypes. Am. J. Hum. Genet. 55: 728-737, 1994. [PubMed: 7942851, related citations]

  3. Gad, A., Laurino, M., Maravilla, K. R., Matsushita, M., Raskind, W. H. Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome? Am. J. Med. Genet. 146A: 1880-1885, 2008. [PubMed: 18553554, images, related citations] [Full Text]

  4. Goulding, M. D., Chalepakis, G., Deutsch, U., Erselius, J. R., Gruss, P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10: 1135-1147, 1991. [PubMed: 2022185, related citations] [Full Text]

  5. Hoth, C. F., Milunsky, A., Lipsky, N., Sheffer, R., Clarren, S. K., Baldwin, C. T. Mutations in the paired domain of the human PAX3 gene causes Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet. 52: 455-462, 1993. [PubMed: 8447316, related citations]

  6. Sommer, A., Bartholomew, D. W. Craniofacial-deafness-hand syndrome revisited. Am. J. Med. Genet. 123A: 91-94, 2003. [PubMed: 14556253, related citations] [Full Text]

  7. Sommer, A., Young-Wee, T., Frye, T. Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness. Am. J. Med. Genet. 15: 71-77, 1983. [PubMed: 6859126, related citations] [Full Text]


Anne M. Stumpf - updated : 02/27/2020
Victor A. McKusick - updated : 1/14/2004
Creation Date:
Victor A. McKusick : 6/4/1986
alopez : 09/22/2023
carol : 04/10/2023
alopez : 02/27/2020
carol : 06/21/2016
carol : 7/1/2009
carol : 6/18/2009
terry : 6/17/2009
tkritzer : 1/15/2004
terry : 1/14/2004
carol : 1/8/2002
carol : 6/18/1998
terry : 2/6/1996
mark : 1/30/1996
mark : 1/24/1996
mimadm : 6/25/1994
supermim : 3/16/1992
supermim : 3/20/1990
ddp : 10/26/1989
marie : 3/25/1988
reenie : 6/4/1986

# 122880

CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS


SNOMEDCT: 702362004;   ORPHA: 1529;   DO: 0111336;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
2q36.1 Craniofacial-deafness-hand syndrome 122880 Autosomal dominant 3 PAX3 606597

TEXT

A number sign (#) is used with this entry because of evidence that craniofacial-deafness-hand syndrome (CDHS) is caused by heterozygous mutation in the PAX3 gene (606597) on chromosome 2q36.


Description

Craniofacial-deafness-hand syndrome (CDHS) is an autosomal dominant disorder characterized by dysmorphic facial features, hand abnormalities, absent or hypoplastic nasal and wrist bones, and severe sensorineural hearing impairment (summary by Gad et al., 2008).


Clinical Features

Sommer et al. (1983) reported a syndrome in mother and infant daughter with features of flat facial profile, hypertelorism, hypoplastic nose with slitlike nares, and a sensorineural hearing loss. Common radiologic findings included small maxilla, absent or small nasal bones, and ulnar deviation of the hands.

Sommer and Bartholomew (2003) provided a follow-up of the family reported by Sommer et al. (1983). A boy born 2 years after the birth of the index patient had precisely the same manifestations as his mother and sister. The mother and daughter were found to have congenital absence of nasolacrimal ducts. The sister and brother grew and developed normally, were very good students, and were active in sports. They were attending college and had goals to be a veterinary technician and a computer technologist, respectively.

Gad et al. (2008) described a 37-year-old woman, born to healthy nonconsanguineous parents, with some, but not all, of the characteristics of CDHS. She had bilateral sensorineural hearing loss, flat facial profile, ptosis, downslanting palpebral fissures, short broad nose, depressed nasal bridge, micrognathia, hypertelorism, telecanthus, high arched palate, limited movement of the wrist with ulnar deviation of the hands, mild flexion contractures of digits 2-5, and clinodactyly of the 5th digits. In addition, CT scan of the face showed underdevelopment of the sinuses ranging from mild to complete aplasia, which had not previously been described in patients with CDHS.


Inheritance

The transmission pattern of CDHS in the family reported by Asher et al. (1996) was consistent with autosomal dominant inheritance.


Molecular Genetics

Because dystopia canthorum, a midfacial alteration, is the most reliable indicator of a PAX3 mutation among Waardenburg syndrome type I families (193500), according to Farrer et al. (1994), and because during murine development the Pax3 gene was expressed in the nasal process (Goulding et al., 1991), Asher et al. (1996) explored the possibility that a mutant allele of PAX3 might be responsible for CDHS. In the mother and child reported by Sommer et al. (1983), Asher et al. (1996) found heterozygosity for a missense mutation (N47K; 606597.0010) in the paired domain of PAX3 by SSCP analysis followed by sequencing. A previously described missense mutation in the same codon (N47H; 606597.0011) was reported by Hoth et al. (1993) in association with Waardenburg syndrome type III (148820). A substitution of a basic amino acid for asparagine at residue 47, conserved in all known murine Pax and human PAX genes, appears to have a more drastic effect on the phenotype than missense, frameshift, and deletion mutations of PAX3 that cause Waardenburg syndrome type I. Among 24 unrelated individuals with WS1 mutations, no 2 had been found to have the same point mutation in the protein-coding region of PAX3, nor did they have a change in the same codon (Farrer et al., 1994). The finding in CDHS provided the first opportunity to compare molecular pathology and clinical heterogeneity between 2 different mutations in the same codon for PAX3.

In a patient with possible CDHS, Gad et al. (2008) performed sequencing of all 9 exons and 20 bp of the flanking introns of the PAX3 gene and did not identify any mutations. The presence of heterozygosity for a PAX3 polymorphism ruled out a full gene deletion, but a partial deletion remained a possible disease mechanism in this patient.


REFERENCES

  1. Asher, J. H., Jr., Sommer, A., Morrell, R., Friedman, T. B. Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome. Hum. Mutat. 7: 30-35, 1996. [PubMed: 8664898] [Full Text: https://doi.org/10.1002/(SICI)1098-1004(1996)7:1<30::AID-HUMU4>3.0.CO;2-T]

  2. Farrer, L. A., Arnos, K. S., Asher, J. H., Jr., Baldwin, C. T., Diehl, S. R., Friedman, T. B., Greenberg, J., Grundfast, K. M., Hoth, C., Lalwani, A. K., Landa, B., Leverton, K., Milunsky, A., Morell, R., Nance, W. E., Newton, V., Ramesar, R., Rao, V. S., Reynolds, J. E., San Agustin, T. B., Wilcox, E. R., Winship, I., Read, A. P. Locus heterogeneity for Waardenburg syndrome is predictive of clinical subtypes. Am. J. Hum. Genet. 55: 728-737, 1994. [PubMed: 7942851]

  3. Gad, A., Laurino, M., Maravilla, K. R., Matsushita, M., Raskind, W. H. Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome? Am. J. Med. Genet. 146A: 1880-1885, 2008. [PubMed: 18553554] [Full Text: https://doi.org/10.1002/ajmg.a.32402]

  4. Goulding, M. D., Chalepakis, G., Deutsch, U., Erselius, J. R., Gruss, P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10: 1135-1147, 1991. [PubMed: 2022185] [Full Text: https://doi.org/10.1002/j.1460-2075.1991.tb08054.x]

  5. Hoth, C. F., Milunsky, A., Lipsky, N., Sheffer, R., Clarren, S. K., Baldwin, C. T. Mutations in the paired domain of the human PAX3 gene causes Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet. 52: 455-462, 1993. [PubMed: 8447316]

  6. Sommer, A., Bartholomew, D. W. Craniofacial-deafness-hand syndrome revisited. Am. J. Med. Genet. 123A: 91-94, 2003. [PubMed: 14556253] [Full Text: https://doi.org/10.1002/ajmg.a.20501]

  7. Sommer, A., Young-Wee, T., Frye, T. Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness. Am. J. Med. Genet. 15: 71-77, 1983. [PubMed: 6859126] [Full Text: https://doi.org/10.1002/ajmg.1320150109]


Contributors:
Anne M. Stumpf - updated : 02/27/2020
Victor A. McKusick - updated : 1/14/2004

Creation Date:
Victor A. McKusick : 6/4/1986

Edit History:
alopez : 09/22/2023
carol : 04/10/2023
alopez : 02/27/2020
carol : 06/21/2016
carol : 7/1/2009
carol : 6/18/2009
terry : 6/17/2009
tkritzer : 1/15/2004
terry : 1/14/2004
carol : 1/8/2002
carol : 6/18/1998
terry : 2/6/1996
mark : 1/30/1996
mark : 1/24/1996
mimadm : 6/25/1994
supermim : 3/16/1992
supermim : 3/20/1990
ddp : 10/26/1989
marie : 3/25/1988
reenie : 6/4/1986